BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3880657)

  • 1. A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma.
    Yau JC; Yap YY; Buzdar AU; Hortobagyi GN; Bodey GP; Blumenschein GR
    Cancer; 1985 Jan; 55(2):337-40. PubMed ID: 3880657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5-day infusion.
    Yap HY; Blumenschein GR; Bodey GP; Hortobagyi GN; Buzdar AU; DiStefano A
    Cancer Treat Rep; 1981; 65(9-10):775-9. PubMed ID: 7273012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of vindesine in patients with metastatic breast cancer.
    Cobleigh MA; Williams SD; Einhorn LH
    Cancer Treat Rep; 1981; 65(7-8):659-63. PubMed ID: 7248983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vindesine as a single agent and in combination with adriamycin in the treatment of metastatic breast carcinoma.
    Smith IE; Coombes RC; Evans BD; Ford HT; Gazet JC; Gordon C; McKinna JA; Powles TJ
    Eur J Cancer (1965); 1980; Suppl 1():271-3. PubMed ID: 7032939
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vindesine and adriamycin in the therapy of metastatic breast cancer].
    Wander HE; Nagel GA
    Onkologie; 1982 Aug; 5 Suppl():5-7. PubMed ID: 6752792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vindesine. A phase II trial in advanced breast cancer patients.
    Robins HI; Tormey DC; Skelley MJ; Falkson G; Crowley JJ; Ramirez G; Falkson H
    Cancer Clin Trials; 1981; 4(4):371-5. PubMed ID: 7318120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
    Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
    Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vindesine in the treatment of metastatic breast cancer.
    Hansen PV; Brincker H
    Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1221-5. PubMed ID: 6541581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of vincristine and vindesine in the treatment of inoperable non-small cell bronchial carcinoma.
    Jewkes J; Harper PG; Tobias JS; Geddes DM; Souhami RL; Spiro SG
    Cancer Treat Rep; 1983 Dec; 67(12):1119-21. PubMed ID: 6360349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.
    Garewal HS; Brooks RJ; Jones SE; Miller TP
    J Clin Oncol; 1983 Dec; 1(12):772-5. PubMed ID: 6422004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vindesine: a new vinca alkaloid.
    Bayssas M; Gouveia J; de Vassal F; Misset JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; Hayat M; Mathé G
    Recent Results Cancer Res; 1980; 74():91-7. PubMed ID: 7003662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of vindesine in patients with advanced breast cancer.
    Walker BK; Raich PC; Fontana J; Subramanian VP; Rogers JS; Knost JA; Denning B
    Cancer Treat Rep; 1982 Sep; 66(9):1729-32. PubMed ID: 6288237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized study of continuous infusion vindesine versus vinblastine in adults with refractory metastatic sarcomas.
    Yap BS; Benjamin RS; Plager C; Burgess MA; Papadoupoulos N; Bodey GP
    Am J Clin Oncol; 1983 Apr; 6(2):235-8. PubMed ID: 6829497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinca alkaloids in the treatment of non-small cell lung cancer.
    Sørensen JB; Osterlind K; Hansen HH
    Cancer Treat Rev; 1987 Mar; 14(1):29-51. PubMed ID: 3036349
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directions.
    Miller TP; Jones SE; Chester AB; Dorr RT
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():81-6. PubMed ID: 7438127
    [No Abstract]   [Full Text] [Related]  

  • 16. Vindesine for metastatic malignant melanoma. A phase II trial.
    Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous intravenous infusion of vinca alkaloid using a subcutaneously implanted pump in a canine model.
    Jackson DV; Barringer ML; Rosenbaum DL; Long TR; Sterchi JM; Meredith W; Sethi VS; Modest EJ; Wells HB; Spurr CL; Castle MC
    Cancer Chemother Pharmacol; 1983; 10(3):217-20. PubMed ID: 6861267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin plus vindesine in advanced breast cancer: a phase II trial of the EORTC Breast Cancer Cooperative Group.
    Paridaens R; Clarysse A; Rozencweig M; Rotmensz N; Heuson JC
    Eur J Cancer Clin Oncol; 1985 May; 21(5):595-9. PubMed ID: 4040025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I trial of combination chemotherapy employing carboplatin, vinca alkaloids, with or without bleomycin in patients with advanced malignant tumors.
    Bajorin D; Kelsen DP
    Cancer Invest; 1990; 8(2):135-41. PubMed ID: 1698110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vindesine and prednisone for remission induction in children with acute lymphocytic leukemia.
    Vats TS; Mehta P; Trueworthy RC; Smith SD; Klopovich P
    Cancer; 1981 Jun; 47(12):2789-92. PubMed ID: 6942907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.